AstraZeneca PLC
25 August 2000
WE HEREBY INFORM YOU THAT ON 23 AUGUST 2000 THE FOLLOWING DIRECTORS OF
ASTRAZENECA PLC WERE GRANTED OPTIONS UNDER THE ASTRAZENECA SHARE OPTION PLAN.
THE OPTIONS ARE EXERCISABLE OVER THE COMPANY'S USD0.25 ORDINARY SHARES.
NAME OF DIRECTOR NUMBER OF EXERCISE PRICE PERIOD WHEN TOTAL
SHARES UNDER PER SHARE EXERCISABLE NUMBER OF
OPTION SHARES UNDER
OPTION
T F W MCKILLOP 29,097 3093P 23.8.03-22.8.10 193,889
H L MOGREN 21,823 3093P 23.8.03-22.8.10 133,282
A B T STAVLING 13,417 3093P 23.8.03-22.8.10 74,497
J R SYMONDS 28,451 3093P 23.8.03-22.8.10 102,155
C E WILHELMSSON 12,932 3093P 23.8.03-22.8.10 81,278
G H R MUSKER
COMPANY SECRETARY
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.